Ritholtz Wealth Management Has $6.61 Million Position in HCA Healthcare, Inc. $HCA

Ritholtz Wealth Management raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 16.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,972 shares of the company’s stock after purchasing an additional 1,996 shares during the period. Ritholtz Wealth Management’s holdings in HCA Healthcare were worth $6,612,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Friedenthal Financial bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $978,000. Fifth Third Wealth Advisors LLC grew its position in HCA Healthcare by 11.5% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,557 shares of the company’s stock valued at $1,210,000 after purchasing an additional 264 shares during the period. OP Asset Management Ltd bought a new position in shares of HCA Healthcare in the first quarter valued at $12,883,000. Apella Capital LLC increased its position in shares of HCA Healthcare by 93.2% during the first quarter. Apella Capital LLC now owns 1,198 shares of the company’s stock worth $585,000 after acquiring an additional 578 shares in the last quarter. Finally, Weaver Capital Management LLC boosted its stake in HCA Healthcare by 24.9% during the 1st quarter. Weaver Capital Management LLC now owns 3,126 shares of the company’s stock valued at $1,479,000 after purchasing an additional 624 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA was highlighted as a top value stock for long-term investors, reinforcing the view that the shares may be attractive based on fundamentals and valuation. Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
• Positive Sentiment: TriStar, part of HCA, received a certificate of need to build a freestanding emergency room in Lebanon, which supports continued facility expansion and local growth. TriStar gains certificate of need to build freestanding ER in Lebanon
• Positive Sentiment: HCA Healthcare Foundation awarded $2.1 million in grants to 89 Middle Tennessee nonprofits, reinforcing community ties and brand goodwill in a core market. 89 Middle Tennessee nonprofits awarded $2.1M in grants by HCA Healthcare Foundation
• Neutral Sentiment: HCA sold 31 home health and hospice agencies, and DAI is acquiring 24 home health agencies from HCA, suggesting ongoing portfolio reshaping but not an obviously major earnings catalyst. HCA sells 31 home health, hospice agencies DAI To Acquire 24 Home Health Agencies From HCA, ‘Doubling Down’ On Care In The Home
• Neutral Sentiment: Coverage on the Frist family and HCA’s history, along with the naming of a new hospital CEO and a healthcare CEO pay list, is largely informational and unlikely to move the stock by itself. Frist family letter reveals the values that built HCA Healthcare by Dr. Thomas Frist Sr. HCA HealthONE names CEO of 2 Denver hospitals 23 highest-paid healthcare CEOs: Wall Street Journal
• Negative Sentiment: HCA’s chief clinical officer is set to exit after four years, creating some leadership turnover at the company. HCA’s chief clinical officer to exit after 4 years

HCA Healthcare Stock Performance

Shares of HCA stock opened at $388.38 on Thursday. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The firm’s 50-day simple moving average is $412.73 and its two-hundred day simple moving average is $466.54. The firm has a market cap of $86.16 billion, a price-to-earnings ratio of 13.36, a P/E/G ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the previous year, the business earned $6.45 EPS. The company’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.73%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Sanford C. Bernstein dropped their target price on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a report on Thursday, June 4th. Argus cut their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, May 4th. JPMorgan Chase & Co. dropped their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 19th. Mizuho increased their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Fifteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $503.00.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.